Cargando…

Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway

Background: Doxorubicin (Dox) can induce endotheliotoxicity and damage the vascular endothelium (VE). The most principle mechanism might be excess reactive oxygen species (ROS) generation. Nevertheless, the characteristics of ROS generation, downstream mechanisms, and target organelles in Dox-induce...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Huan, Wang, Liang, Qiao, Yang, Zhou, Qing, Li, Hongwei, Chen, Shuping, Yin, Dong, Huang, Qing, He, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965327/
https://www.ncbi.nlm.nih.gov/pubmed/31998130
http://dx.doi.org/10.3389/fphar.2019.01531
_version_ 1783488618201874432
author He, Huan
Wang, Liang
Qiao, Yang
Zhou, Qing
Li, Hongwei
Chen, Shuping
Yin, Dong
Huang, Qing
He, Ming
author_facet He, Huan
Wang, Liang
Qiao, Yang
Zhou, Qing
Li, Hongwei
Chen, Shuping
Yin, Dong
Huang, Qing
He, Ming
author_sort He, Huan
collection PubMed
description Background: Doxorubicin (Dox) can induce endotheliotoxicity and damage the vascular endothelium (VE). The most principle mechanism might be excess reactive oxygen species (ROS) generation. Nevertheless, the characteristics of ROS generation, downstream mechanisms, and target organelles in Dox-induced endotheliotoxicity have yet to be elucidated. Methods and Results: In order to explore the related problems, the VE injury models were established in mice and human umbilical vein endothelial cells (HUVECs) by Dox-induced endotheliotoxicity. Results showed that the activities of lactate dehydrogenase (LDH) and creatine kinase of mice’s serum increased after injected Dox. The thoracic aortic strips’ endothelium-dependent dilation was significantly impaired, seen noticeable inflammatory changes, and brown TUNEL-positive staining in microscopy. After Dox-treated, HUVECs viability lowered, LDH and caspase-3 activities, and apoptotic cells increased. Both intracellular/mitochondrial ROS generation significantly increased, and intracellular ROS generation lagged behind mitochondria. HUVECs treated with Dox plus ciclosporin A (CsA) could basically terminate ROS burst, but plus edaravone (Eda) could only delay or inhibit, but could not completely cancel ROS burst. Meanwhile, the expression of endothelial nitric oxide synthase (eNOS) decreased, especially phosphorylation of eNOS significantly. Then nitric oxide content decreased, the mitochondrial function was impaired, mitochondrial membrane potential (MMP) impeded, mitochondrial swelled, mitochondrial permeability transition pore (mPTP) was opened, and cytochrome C was released from mitochondria into the cytosol. Conclusion: Dox produces excess ROS in the mitochondria, thereby weakens the MMP, opens mPTP, activates the ROS-induced ROS release mechanism, induces ROS burst, and leads to mitochondrial dysfunction, which in turn damages VE. Therefore, interrupting any step of the cycles, as mentioned above can end the related vicious cycle and prevent the occurrence and development of injury.
format Online
Article
Text
id pubmed-6965327
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-69653272020-01-29 Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway He, Huan Wang, Liang Qiao, Yang Zhou, Qing Li, Hongwei Chen, Shuping Yin, Dong Huang, Qing He, Ming Front Pharmacol Pharmacology Background: Doxorubicin (Dox) can induce endotheliotoxicity and damage the vascular endothelium (VE). The most principle mechanism might be excess reactive oxygen species (ROS) generation. Nevertheless, the characteristics of ROS generation, downstream mechanisms, and target organelles in Dox-induced endotheliotoxicity have yet to be elucidated. Methods and Results: In order to explore the related problems, the VE injury models were established in mice and human umbilical vein endothelial cells (HUVECs) by Dox-induced endotheliotoxicity. Results showed that the activities of lactate dehydrogenase (LDH) and creatine kinase of mice’s serum increased after injected Dox. The thoracic aortic strips’ endothelium-dependent dilation was significantly impaired, seen noticeable inflammatory changes, and brown TUNEL-positive staining in microscopy. After Dox-treated, HUVECs viability lowered, LDH and caspase-3 activities, and apoptotic cells increased. Both intracellular/mitochondrial ROS generation significantly increased, and intracellular ROS generation lagged behind mitochondria. HUVECs treated with Dox plus ciclosporin A (CsA) could basically terminate ROS burst, but plus edaravone (Eda) could only delay or inhibit, but could not completely cancel ROS burst. Meanwhile, the expression of endothelial nitric oxide synthase (eNOS) decreased, especially phosphorylation of eNOS significantly. Then nitric oxide content decreased, the mitochondrial function was impaired, mitochondrial membrane potential (MMP) impeded, mitochondrial swelled, mitochondrial permeability transition pore (mPTP) was opened, and cytochrome C was released from mitochondria into the cytosol. Conclusion: Dox produces excess ROS in the mitochondria, thereby weakens the MMP, opens mPTP, activates the ROS-induced ROS release mechanism, induces ROS burst, and leads to mitochondrial dysfunction, which in turn damages VE. Therefore, interrupting any step of the cycles, as mentioned above can end the related vicious cycle and prevent the occurrence and development of injury. Frontiers Media S.A. 2020-01-10 /pmc/articles/PMC6965327/ /pubmed/31998130 http://dx.doi.org/10.3389/fphar.2019.01531 Text en Copyright © 2020 He, Wang, Qiao, Zhou, Li, Chen, Yin, Huang and He http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
He, Huan
Wang, Liang
Qiao, Yang
Zhou, Qing
Li, Hongwei
Chen, Shuping
Yin, Dong
Huang, Qing
He, Ming
Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title_full Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title_fullStr Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title_full_unstemmed Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title_short Doxorubicin Induces Endotheliotoxicity and Mitochondrial Dysfunction via ROS/eNOS/NO Pathway
title_sort doxorubicin induces endotheliotoxicity and mitochondrial dysfunction via ros/enos/no pathway
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965327/
https://www.ncbi.nlm.nih.gov/pubmed/31998130
http://dx.doi.org/10.3389/fphar.2019.01531
work_keys_str_mv AT hehuan doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT wangliang doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT qiaoyang doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT zhouqing doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT lihongwei doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT chenshuping doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT yindong doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT huangqing doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway
AT heming doxorubicininducesendotheliotoxicityandmitochondrialdysfunctionviarosenosnopathway